Abstract
We treated a 67-year-old female with hypopharyngeal cancer (T2N0) in the posterior wall, who had a complete response after two cycles of chemotherapy with docetaxel followed by radiation. Five years after this therapy she has had no recurrence and no metastasis, with preserved laryngeal framework and function. Docetaxel is useful for treating early head and neck cancer.
MeSH terms
-
Aged
-
Antineoplastic Agents, Phytogenic / administration & dosage*
-
Carcinoma, Squamous Cell / therapy*
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Docetaxel
-
Female
-
Humans
-
Hypopharyngeal Neoplasms / therapy*
-
Paclitaxel / administration & dosage*
-
Paclitaxel / analogs & derivatives*
-
Taxoids*
Substances
-
Antineoplastic Agents, Phytogenic
-
Taxoids
-
Docetaxel
-
Paclitaxel